BPC-157 10mg + TB-500 10mg + GHK-CU 100mg

Tri-Regenerative Complex — BPC-157 10mg + TB-500 10mg + GHK-CU 100mg Research Bundle UK

The Tri-Regenerative Complex adds GHK-CU 100mg to the BPC-157 and TB-500 pairing, forming a three-compound recovery research bundle. GHK-CU is a copper-binding tripeptide (Gly-His-Lys coordinated to Cu2+) with a documented gene-expression profile spanning collagen synthesis, extracellular matrix biology, and antioxidant signalling — a mechanism distinct from both BPC-157’s nitric oxide/VEGF signalling and TB-500’s actin-binding cytoskeletal activity. The three compounds are mechanistically non-overlapping, allowing each to function as an independent variable within a combined recovery research protocol.

Sourcing all three compounds as a single-supplier bundle provides batch consistency across the research protocol, with each peptide tested against the same documentation standard by the same independent laboratory.

Every compound in the Tri-Regenerative Complex is independently tested by Janoshik laboratory. HPLC purity is confirmed at ≥98% on all three compounds, with LC-MS molecular identity verification. Batch-specific Certificates of Analysis are publicly accessible for BPC-157, TB-500, and GHK-CU before purchase.

For laboratory handling purposes, all three lyophilised peptides may be reconstituted using BP-grade bacteriostatic water or saline, and stored at -20°C, avoiding repeated freeze-thaw cycles. GHK-CU should be protected from prolonged light exposure to preserve the Cu2+ chromophore.

For complete mechanism detail on each compound, see the BPC-157, TB-500, and GHK-Cu research guides on the Ascend Peptides UK blog, or the recovery research peptides category page.

WADA Status: BPC-157 and TB-500 are listed on the WADA Prohibited List, prohibited at all times.

DISCLAIMER: For in-vitro laboratory research only. Not for human consumption, therapeutic, diagnostic, or clinical use. Not classified as a medicinal product by the MHRA.